| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0074 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |